Breast cancer-related mortality in Central and Eastern Europe: years of life lost and productivity costs
G Bencina, N Chami, R Hughes, G Weston… - Journal of Medical …, 2023 - Taylor & Francis
Background Breast cancer (BC) poses a public health challenge as the most commonly
diagnosed cancer among women globally. While BC mortality has declined across Europe …
diagnosed cancer among women globally. While BC mortality has declined across Europe …
[HTML][HTML] EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe
M Ignatiadis, F Poulakaki, T Spanic, E Brain… - European Journal of …, 2024 - Elsevier
Abstract The European Breast Cancer Council (EBCC) traditionally identifies controversies
or major deficiencies in the management of patients with breast cancer and selects a …
or major deficiencies in the management of patients with breast cancer and selects a …
Higher disease burden and lower utilization in mongolian with breast cancer: a 9-year retrospective cohort study of 18.19 million adults in China
J Chen, L Qiao, M Qi, Y Zhang, Y Yan… - … Journal of Surgery, 2024 - journals.lww.com
Background: Whether health inequalities of disease burden and medical utilization exist by
ethnicity in Asian breast cancer (BC) patients remains unclear. We aim to measure ethnic …
ethnicity in Asian breast cancer (BC) patients remains unclear. We aim to measure ethnic …
Cost-effectiveness of 2-[18F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study
We evaluated the cost-effectiveness of 2-[18F] FDG-PET/CT compared to CE-CT for
response monitoring in metastatic breast cancer (MBC) patients. The study included 300 …
response monitoring in metastatic breast cancer (MBC) patients. The study included 300 …
A retrospective cohort study to evaluate disease burden, health care resource utilization, and costs in patients with breast cancer in Dubai, UAE
DMM Hamza, MWA Zayed, N Tahoun… - BMC Health Services …, 2024 - Springer
Background The current study evaluated the disease burden, health care resource
utilization and analyzed the cost burden due to events of special interest among patients …
utilization and analyzed the cost burden due to events of special interest among patients …
Monitoring treatment response in metastatic breast cancer: impact of FDG-PET/CT on survival and costs
M Naghavi-Behzad - 2023 - portal.findresearcher.sdu.dk
Background: Various diagnostic modalities are being used for staging metastatic disease in
breast cancer patients since international guidelines do not yet provide clear …
breast cancer patients since international guidelines do not yet provide clear …
A Review of Mobile Applications' Features for Pregnant Women's Self-care
Z Fathifar, F Qorbanzadeh, Z Saeedi… - Depiction of …, 2023 - doh.tbzmed.ac.ir
Mobile applications have been proposed as a helpful tool to provide health-related
information to people, and this is more important in pregnancy-related mobile applications …
information to people, and this is more important in pregnancy-related mobile applications …
[引用][C] Wide variation in hospital costs for advanced breast cancer
PP Schneider - PharmacoEconomics & Outcomes News, 2021 - Springer
There appears to be wide variation in hospital costs in patients with advanced breast cancer
(ABC) in the Netherlands, according to findings of a real-world study published in Value in …
(ABC) in the Netherlands, according to findings of a real-world study published in Value in …